Cumberland Projects Cash Will Fund Operations for More Than Five Years

Your call?🐂 Bullish🐻 Bearish

Cumberland is preparing a new drug application under the FDA’s rolling-review process for ifetroban to treat cardiomyopathy associated with Duchenne muscular dystrophy.